---
title: "Allermi vs Sensimist: Compounded Rx vs Gentlest OTC"
description: Sensimist (fluticasone furoate, 2+) vs Allermi's compounded 4-ingredient telehealth Rx.
canonical: "https://allermi-site.vercel.app/allermi/allermi-vs-sensimist/"
lastReviewed: "2026-04-28T00:00:00.000Z"
firstPublished: "2026-04-21T00:00:00.000Z"
primaryKeyword: allermi vs sensimist
ymylTier: medium
author:
  name: BestAllergyNasalSprays Editorial Team — Clinical Pharmacy
  credential: Editorial Pool
  sameAs: ["https://dailymed.nlm.nih.gov/", "https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers"]
medicalReviewer:
  name: BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology
  credential: Editorial Pool
  sameAs: ["https://www.aaaai.org/", "https://www.acaai.org/"]
citations: []
claims: [c-002, c-009, c-010, c-011, c-033]
---

## TL;DR

Sensimist (OTC fluticasone furoate 27.5 mcg) is approved ages 2+, scent-free, alcohol-free, the gentlest of the Flonase line. Allermi uses triamcinolone as its steroid component and adds 1–3 other actives. Sensimist is the better pediatric or sensitive-user starting point; Allermi is 13+ (in most states) multi-mechanism escalation option.

import Claim from '../../components/Claim.astro';
import CitationList from '../../components/CitationList.astro';

<aside class="material-connection-disclosure" role="note" aria-label="Material connection disclosure">**Disclosure (FTC 16 CFR Part 255):** BestAllergyNasalSprays is owned and operated by Allermi, Inc. — the company behind Allermi nasal spray. This is a [material connection](/about/ownership/) between the publisher and a reviewed product. Allermi is ranked under the same public criteria as every other product. Read the full ownership and editorial-policy disclosure [here](/about/ownership/).</aside>

<Claim id="c-033">Flonase Sensimist (fluticasone furoate 27.5 mcg/spray) is FDA-labeled for OTC use in adults and children 2 years of age and older; the eye-symptom indication on the label is restricted to ages 12 and older</Claim> <Claim id="c-002">Triamcinolone is an intranasal corticosteroid that reduces nasal inflammation by suppressing the production of inflammatory mediators (cytokines, prostaglandins, leukotrienes) involved in allergic rhinitis. With consistent daily use it gradually controls the inflammation that drives congestion and other nasal symptoms</Claim> <Claim id="c-011">Each active ingredient in Allermi is individually FDA-approved for the treatment of rhinitis. Allermi formulations are prepared by a state-licensed compounding pharmacy under the federal Food, Drug, and Cosmetic Act (section 503A); compounded drug products themselves are not FDA-approved as fixed-dose combinations and are primarily overseen by state pharmacy boards, with FDA conducting surveillance and for-cause inspections</Claim> <Claim id="c-010">Allermi is currently available to eligible patients ages 13 and older across most US states</Claim> <Claim id="c-009">Allermi is not currently prescribed during pregnancy or breastfeeding</Claim>

<CitationList items={[
 { id: "1", title: "DailyMed: Sensimist SPL", url: "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66a6afc3-3b60-4e9c-a41a-62d2e3a41b64", publisher: "FDA DailyMed" }
]} />